SFM
ASND icon

Soros Fund Management’s Ascendis Pharma A/S ASND Stock Holding History

Soros Fund Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100,000
Closed -$13.6M – 187
2024
Q2 		$13.6M Buy
100,000
+96,568
+2,814% +$13.1M 0.25% 98
2024
Q1 		$519K Buy
+3,432
New +$490K 0.01% 189

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Soros Fund Management's ASND Position: Q3 2024 in Review

Soros Fund Management sold out of Ascendis Pharma A/S (ASND) in Q3 2024, closing a stake of 100,000 shares — an estimated $13.6M sold.

Soros Fund Management first reported a position in ASND in Q1 2024 and held it in 2 quarters. The position peaked at $13.6M in Q2 2024. 219 funds tracked by Wall St. Rank hold ASND as of Q3 2024.

  • Soros Fund Management reported no remaining Ascendis Pharma A/S position as of Q3 2024 after selling out during the quarter.
  • Soros Fund Management sold 100,000 Ascendis Pharma A/S shares in Q3 2024, an estimated $13.6M.
  • Soros Fund Management first reported a position in Ascendis Pharma A/S in Q1 2024 and held it in 2 quarters.
  • Soros Fund Management's Ascendis Pharma A/S position peaked at $13.6M in Q2 2024.
  • 219 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2024.

Based on Soros Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.